Personal information

Spain

Activities

Education and qualifications (1)

Universidad AutĂłnoma de Madrid Facultad de Medicina: Madrid, Madrid, ES

2012-12-21 to present | Doctor
Education
Source: Self-asserted source
ANTONIO HERRERA MERCHAN

Works (12)

The value of lncRNA FENDRR and FOXF1 as a prognostic factor for survival of lung adenocarcinoma

Oncotarget
2017-10-27 | Journal article
Source: Self-asserted source
ANTONIO HERRERA MERCHAN

Long Noncoding RNAs as Cancer Biomarkers

Cancer and Noncoding RNAs
2017-10-02 | Book chapter
Source: Self-asserted source
ANTONIO HERRERA MERCHAN

Preoperative chemoradiotherapy for rectal cancer: the sensitizer role of the association between miR-375 and c-Myc

Oncotarget
2017-07-19 | Journal article
Source: Self-asserted source
ANTONIO HERRERA MERCHAN

BRG1 regulation by miR-155 in human leukemia and lymphoma cell lines

Clinical and Translational Oncology
2017-03-01 | Journal article
Source: Self-asserted source
ANTONIO HERRERA MERCHAN

A Mechanistic Study of lncRNA Fendrr Regulation of FoxF1 Lung Cancer Tumor Supressor

Bioinformatics and Biomedical Engineering
2016 | Other
Part of ISBN: 9783319317434
Part of ISSN: 0302-9743
Contributors: Carmen Navarro; Carlos Cano; Marta Cuadros; Antonio Herrera-Merchan; Miguel Molina; Armando Blanco
Source: Self-asserted source
ANTONIO HERRERA MERCHAN via Crossref Metadata Search

Choosing the right cell line for rectal cancer research

Archivos de Medicina Universitaria
2015-09-06 | Journal article
Source: Self-asserted source
ANTONIO HERRERA MERCHAN

Anti-cancer and Anti-angiogenic Properties of Various Natural Pentacyclic Tri-terpenoids and Some of their Chemical Derivatives

Current Organic Chemistry
2015-05 | Journal article
Part of ISSN: 1385-2728
Contributors: Eva E. Rufino-Palomares; Amalia Perez-Jimenez; Fernando J. Reyes-Zurita; Leticia Garcia- Salguero; Khalida Mokhtari; Antonio Herrera-Merchan; Pedro P. Medina; Juan Peragon; Jose A. Lupianez
Source: Self-asserted source
ANTONIO HERRERA MERCHAN via Crossref Metadata Search

Ezh1 is required for hematopoietic stem cell maintenance and prevents senescence-like cell cycle arrest.

2012-11 | Journal article
Contributors: Hidalgo I; Herrera-Merchan A; Ligos JM; Carramolino L; Nuñez J; Martinez F; Dominguez O; Torres M; Gonzalez S
Source: Self-asserted source
ANTONIO HERRERA MERCHAN via Europe PubMed Central

Therapeutic Polycomb Targeting in Human Cancer

Recent Patents on Regenerative Medicine
2012-07 | Journal article
Part of ISSN: 2210-2973
Contributors: Lorena Arranz; Antonio Herrera-Merchan; Susana Gonzalez
Source: Self-asserted source
ANTONIO HERRERA MERCHAN via Crossref Metadata Search

Insights Into Stem Cell Aging

Advances in Hematopoietic Stem Cell Research
2012-01 | Other
Part of ISBN: 9789533079301
Contributors: A. Herrera-Merchan; I. Hidalgo; L. Arranz; S. Gonzalez
Source: Self-asserted source
ANTONIO HERRERA MERCHAN via Crossref Metadata Search

Therapeutic Polycomb Targeting in Human Cancer

Recent Patents on Regenerative Medicine
2012-01-01 | Book chapter
Source: Self-asserted source
ANTONIO HERRERA MERCHAN

miR-33-mediated downregulation of p53 controls hematopoietic stem cell self-renewal.

2010-08 | Journal article
Contributors: Herrera-Merchan A; Cerrato C; Luengo G; Dominguez O; Piris MA; Serrano M; Gonzalez S
Source: Self-asserted source
ANTONIO HERRERA MERCHAN via Europe PubMed Central